Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Henning

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseasesArik Bernard Schulze, Georg Evers, Andreas Kümmel, et al.
BMJ Open|May 29, 2026
Medication concentrations in human milk and potential adverse effects in breastfed infants (MedMilk): a protocol for an observational clinical studyDitte Resendal Gotfredsen, Ida Marie Heerfordt, Pernille Kähler Byskov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growthLars Henning Schmidt, Tilmann Spieker, Steffen Koschmieder, et al.
Oncology Letters|October 8, 2014
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisMichael Mohr, Christoph Schliemann, Christoph Biermann, et al.
Frontiers in Genetics|October 13, 2023
Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfallsLine Dahl Jeppesen, Lotte Hatt, Ripudaman Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Cancer Research Communications|December 10, 2025
Targeting uPARAP with an antibody-drug conjugate exhibits efficacy against mesothelioma and synergizes with cisplatinPınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Hypertension (Dallas, Tex. : 1979)|August 10, 2005
Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysisVera Jankowski, Raymond Vanholder, Markus van der Giet, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseasesArik Bernard Schulze, Georg Evers, Andreas Kümmel, et al.
BMJ Open|May 29, 2026
Medication concentrations in human milk and potential adverse effects in breastfed infants (MedMilk): a protocol for an observational clinical studyDitte Resendal Gotfredsen, Ida Marie Heerfordt, Pernille Kähler Byskov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growthLars Henning Schmidt, Tilmann Spieker, Steffen Koschmieder, et al.
Oncology Letters|October 8, 2014
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisMichael Mohr, Christoph Schliemann, Christoph Biermann, et al.
Frontiers in Genetics|October 13, 2023
Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfallsLine Dahl Jeppesen, Lotte Hatt, Ripudaman Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Cancer Research Communications|December 10, 2025
Targeting uPARAP with an antibody-drug conjugate exhibits efficacy against mesothelioma and synergizes with cisplatinPınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancerLars Henning Schmidt, Janine Stucke-Ring, Caroline Brand, et al.
Hypertension (Dallas, Tex. : 1979)|August 10, 2005
Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysisVera Jankowski, Raymond Vanholder, Markus van der Giet, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Pageof 18